tm
Seeing Is Believing
tm
Seeing Is Believing
Brooklyn Immunotherapeutics's activity chart (see below) currently has 7 price targets and 7 ratings on display.
Analysts average stock forecasts to be materialized ratio is 66.67% with an average time for these price targets to be met of 503.67 days.
Most recent stock forecast was given by JASON MCCARTHY from MAXIM GROUP on 12-Oct-2022. First documented stock forecast 23-Jan-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 23-Jan-2019
$5
3 years 11 months 10 days ago
(12-Oct-2022)
2/2 (100%)
$-1.63 (-24.59%)
413
Buy Since 29-Dec-2021
$111.68
4 years 8 months 21 days ago
(01-Jan-2022)
0/1 (0%)
$102.98 (1183.68%)
Buy Since 18-Mar-2019
$5
$-3.59 (-41.79%)
$6
7 years 6 months 4 days ago
(18-Mar-2019)
2/2 (100%)
$5 (0.00%)
1098
What is BTX (Brooklyn Immunotherapeutics) average time for price targets to be met?
Which analyst most recently updated their price target on BTX (Brooklyn Immunotherapeutics)?
Which analyst has the current lower performing score on BTX (Brooklyn Immunotherapeutics) with a proven track record?
Which analyst has the most public recommendations on BTX (Brooklyn Immunotherapeutics)?
Which analyst is the currently most bullish on BTX (Brooklyn Immunotherapeutics)?
Which analyst is the currently most reserved on BTX (Brooklyn Immunotherapeutics)?
